Hospital de la Familia
Hospital de la Familia
México, Mexicali
Marco Sariñana
18 tahun pengalaman
Klinik telah bersertifikat :
| México | Turki | Austria | |
| Imunoterapi untuk kanker prostat | dari $35,000 | dari $12,000 | dari $30,000 |
Eslie Perez membawa keahlian dalam perawatan invasif minimal dan terapi inovatif ke Holistic Bio Spa®. Latar belakangnya yang beragam mencakup pelatihan khusus untuk terapi lanjutan.
Dengan lebih dari 15 tahun di bidang medis, dokter adalah Ahli Bedah Estetika & Penurunan Berat Badan yang dihormati, yang mengkhususkan diri dalam menggabungkan prosedur penurunan berat badan dan kosmetik. Dokter telah melakukan lebih dari 2.000 operasi penurunan berat badan dan 1.000 prosedur kosmetik. Sebagai peserta aktif dalam konferensi medis di seluruh Meksiko, dokter berbagi keahlian dalam teknik bedah penurunan berat badan dan prosedur kosmetik.<\/p>
Dokter menawarkan operasi seperti bypass lambung, operasi lengan lambung, balon lambung, operasi obesitas, dan penjahitan lambung. Dokter lulus dari Fakultas Kedokteran UABC di Mexicali, dilatih dalam Bedah Laparoskopi dan Bariatrik Lanjutan di Tijuana, dan memiliki Sertifikasi Magister dalam Bedah Kosmetik & Estetika dari Veracruz.<\/p>
Dokter adalah anggota Asosiasi Meksiko untuk Bedah Endoskopi dan Consejo Mexicano de Especialistas de Cirugia Estetica (CMEQCE).<\/p>
Mexico offers drug-based immune checkpoint inhibitors and cellular therapies like dendritic cell vaccines for prostate cancer. Patients choose centers in Puerto Vallarta and Monterrey for advanced biological protocols and regenerative treatments. These therapies often target metastatic or castration-resistant stages at lower costs than in the United States.
Bookimed Expert Insight: While many seek low-cost checkpoint inhibitors, the real value in Mexico lies in clinic-specific biological protocols. For example, Immunotherapy Regenerative Medicine serves 1,200 patients annually using a deep team of biologists. This concentration of laboratory expertise often exceeds what is found in standard outpatient oncology clinics.
Patient Consensus: Patients value the availability of biosimilar drugs and specialized vaccines. Many emphasize the importance of verifying regulatory status and efficacy when considering lower-cost local alternatives to expensive US-approved therapies.
Immunotherapy effectively treats advanced or metastatic prostate cancer in patients with specific genetic biomarkers. While prostate tumors are often immunologically cold, treatments like therapeutic vaccines and checkpoint inhibitors offer survival benefits. These therapies are most successful for metastatic castration-resistant disease after hormone therapy fails.
Bookimed Expert Insight: Mexico centers like Immunotherapy Regenerative Medicine serve 1,200 patients annually using advanced protocols. Data shows specialized clinics often integrate mesenchymal stem cells with standard oncology care. This approach aims to prime the immune system before starting drug-based therapy. Patients can save up to 56% compared to average US costs of $102,500.
Patient Consensus: Patients emphasize requesting MSI and TMB genetic testing before starting any treatment. Many report that clinical trials provide the best access to these high-cost cutting-edge therapies.